Skip to main content

Table 4 Antimicrobial administration for 150 patients over 2107 patient-days in the ICU

From: Probiotics: Prevention of Severe Pneumonia and Endotracheal Colonization Trial—PROSPECT: a pilot trial

Daily receipt of antimicrobials, n (%)

N = 2107 patient-days in ICU

 Antibiotic

1333 (63.3)

 Antifungal

192 (9.1)

 Antiviral

44 (2.1)

 Antibiotic or antifungal

1392 (66.1)

 Any antimicrobial (antibiotic or antifungal or antiviral)

1397 (66.3)

 Antimicrobial (antibiotic or antifungal) free days

715 (33.9)

Ever in ICU up to day 60, n (%)

N = 150 patients

 Antibiotic received

139 (92.7)

 Antifungal received

14 (9.3)

 Antiviral received

12 (8.0)

 Antibiotic or antifungal received

139 (92.7)

 Any antimicrobial (antibiotic or antifungal or antiviral) received

140 (93.3)

 No antibiotic or antifungal ever received

11 (7.3)

Days of antimicrobial receipt, median (quartile 1 to quartile 3)

N = 139 patients

 Only in patients who received the antimicrobial

 

 Days on antibiotic

7 (3–12)

 Days on antifungal

10.5 (5–19)

 Days on antiviral

2 (1.5–5)

 Days on antibiotic or antifungal

8 (3–13)

 Days on any antimicrobial (antibiotic or antifungal or antiviral)

7.5 (3–12.5)